Sun Feb 5 00:43:08 SGT 2012  
    SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6100 7446 (SHIM)
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Oral Contraceptive | Shim Clinic, Singapore

Share |
Summary

Oral Contraceptive | Shim Clinic, Singapore: Combined oral contraceptive (COC, OC) clinic, Singapore. Definitions, references, and latest news.

Description

Two types of female oral contraceptives are widely available:

Two brands of combined oral contraceptive are available at Shim Clinic:
  • Microgynon® 30
  • Yaz®
Diane-35® is registered in Singapore as an anti-androgen for acne control in females. But it is also an oral contraceptive.

References


Latest News

Anti-Mullerian Hormone: A Potential New Tool in Epidemiologic Studies of Female Fecundability
Fri, 03 Feb 2012 05:00:00 +0100 | American Journal of Epidemiology
The objective of the present commentary is to suggest that epidemiologists explore the use of anti-Müllerian hormone (AMH) as a new measurement tool in fecundability studies. The authors briefly summarize the advantages and limitations of the 3 current approaches to studies of fecundability. All 3 approaches involve the collection of time-to-pregnancy or attempt-time data, and most are limited to participants who plan their pregnancies. AMH is produced by ovarian follicles during their early growth stages and is measured clinically to assess ovarian reserve (the number of remaining oocytes). Unlike time to pregnancy, serum AMH level can be assessed regardless of pregnancy-attempt status. Measurements are not significantly affected by phase of the menstrual cycle, oral contraceptive us...

Effect of Ethinyl estradiol/ Levonorgestrel combined oral contraceptive on the activity of Cytochrome P4503A in obese women.
Thu, 02 Feb 2012 05:00:00 +0100 | British Journal of Clinical Pharmacology
Conclusions:  Although we hypothesized that obesity exposure might amplify the impact on CYP3A4/5 activity in COC users, we found that this was not the case. This finding is reassuring regarding potential additional drug‐drug interactions in obese COC users as CYP3A4/5 is a major player in the metabolism of many marketed drugs.© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society (Source: British Journal of Clinical Pharmacology)

Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Wed, 01 Feb 2012 13:25:00 +0100 | FDA MedWatch
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. (Source: FDA MedWatch)

Procedures to improve prescribing and dispensing of oral contraceptives at an academic medical center.
Wed, 25 Jan 2012 14:48:31 +0100 | American Journal of Health-System Pharmacy : AJHP
Conclusion A review of existing processes for the use of oral contraceptives led to the identification of several strategies to improve prescribing and dispensing practices. Strategies to improve medication safety included reducing the number of oral contraceptive products on the formulary, modifying the CPOE system to restrict ordering to formulary products, dispensing only tablets that contain active drug, and repackaging oral contraceptives in unit dose form. PMID: 22261948 [PubMed - in process] (Source: American Journal of Health-System Pharmacy : AJHP)

Corrigendum: general and central obesity, combined oral contraceptive use and hypertension in chinese women.
Wed, 25 Jan 2012 06:48:22 +0100 | American Journal of Hypertension
Authors: PMID: 22262257 [PubMed - in process] (Source: American Journal of Hypertension)

Contraceptive ---- could help reduce severity of dysmenorrhea
Tue, 24 Jan 2012 03:38:07 +0100 | MedWire News - Ob/Gyn
The combined oral contraceptive ---- could help reduce the severity of dysmenorrhea, say Swedish researchers. (Source: MedWire News - Ob/Gyn)

Painful Period Symptoms Reduced By Oral Contraceptive ----
Thu, 19 Jan 2012 16:00:00 +0100 | Health News from Medical News Today
�In the United States, painful periods (Dysmenorrhoea) are estimated to cause 600 million lost working hours and cost two billion dollars in lost productivity. A large Scandinavian study published online in Europe's leading reproductive medicine journal Human Reproduction, has finally provided compelling evidence, after running for 30 years, that the combined oral contraceptive ---- does indeed relieve symptoms of painful menstrual periods, known as dysmenorrhoea... (Source: Health News from Medical News Today)

Convincing Evidence That The Combined Oral Contraceptive ---- Helps Painful Periods
Thu, 19 Jan 2012 08:00:00 +0100 | Health News from Medical News Today
A large Scandinavian study that has been running for 30 years has finally provided convincing evidence that the combined oral contraceptive ---- does, indeed, alleviate the symptoms of painful menstrual periods - dysmenorrhoea. The research is published online in Europe's leading reproductive medicine journal Human Reproduction [1]... (Source: Health News from Medical News Today)

Painful Periods - Combined Oral Contraceptive ---- Helps
Wed, 18 Jan 2012 20:00:00 +0100 | Health News from Medical News Today
Symptoms of painful menstrual periods are alleviated by taking the combined oral contraceptive ----, according to compelling evidence from a Scandinavian 30-year study which was reported in the journal Human Reproduction this week. Although previous studies pointed towards some kind of link between oral contraception and period pain relief, a 2009 Cochrane Collaboration review concluded that most of them had inconclusive or anecdotal evidence... (Source: Health News from Medical News Today)


ABOUT TRUST ONLINE